secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001558370-25-010508
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics Q2 revenue $6.6M (+37% YoY); net loss narrows to $14.5M
------------------------------------------------------------------

- Revenue $6.6M, up 37% YoY, driven by 79% U.S. new patient starts growth to $4.9M.
- Net loss $14.5M ($0.02 loss per share) vs $20.3M loss in Q2 2024; gross profit $3.1M vs $0.3M.
- FY2025 revenue guidance reaffirmed at $34-38M; gross margins expected 32.5%-37.5%.
- Raised $77.8M gross proceeds ($57.5M public offering + $20.3M Abbott private placement).
- Entered development agreement with Sequel Med Tech to integrate Eversense 365 with twiist AID system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000155837025010508/0001558370-25-010508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000155837025010508/sens-20250806x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-010508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer